发明名称 Protocol for monitoring direct thrombin inhibition
摘要 A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
申请公布号 US8008086(B2) 申请公布日期 2011.08.30
申请号 US20070753071 申请日期 2007.05.24
申请人 CORA HEALTHCARE, INC. 发明人 COHEN ELI;COHEN ROSLYN
分类号 G01N33/86;G01N33/48 主分类号 G01N33/86
代理机构 代理人
主权项
地址